Atlas Trials

miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome

Clinical trial NCT02418195 · COMPLETED

Trial details

NCT number
NCT02418195
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2015-04-20
Primary completion
2020-12-30
Enrollment
247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.